| Consensus guidelines for the definition, detection and interpretation of immunogenic cell death L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ... Journal for immunotherapy of cancer 8 (1), 2020 | 945 | 2020 |
| Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression DMS Hossain, S Javaid, M Cai, C Zhang, A Sawant, M Hinton, M Sathe, ... The Journal of clinical investigation 128 (2), 644-654, 2018 | 206 | 2018 |
| TLR9-targeted STAT3 silencing abrogates immunosuppressive activity of myeloid-derived suppressor cells from prostate cancer patients DMS Hossain, SK Pal, D Moreira, P Duttagupta, Q Zhang, H Won, J Jones, ... Clinical Cancer Research 21 (16), 3771-3782, 2015 | 200 | 2015 |
| Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts S Bhattacharyya, D Md Sakib Hossain, S Mohanty, G Sankar Sen, ... Cellular & molecular immunology 7 (4), 306-315, 2010 | 191 | 2010 |
| Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer GS Sen, S Mohanty, DMS Hossain, S Bhattacharyya, S Banerjee, ... Journal of Biological Chemistry 286 (49), 42232-42247, 2011 | 145 | 2011 |
| Retracted: FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells DMS Hossain, AK Panda, A Manna, S Mohanty, P Bhattacharjee, ... Immunity 39 (6), 1057-1069, 2013 | 140 | 2013 |
| TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo Q Zhang, DMS Hossain, S Nechaev, A Kozlowska, W Zhang, Y Liu, ... Blood, The Journal of the American Society of Hematology 121 (8), 1304-1315, 2013 | 125 | 2013 |
| Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity DMS Hossain, C Dos Santos, Q Zhang, A Kozlowska, H Liu, C Gao, ... Blood, The Journal of the American Society of Hematology 123 (1), 15-25, 2014 | 115 | 2014 |
| Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk A Adhikary, S Mohanty, L Lahiry, DMS Hossain, S Chakraborty, T Das FEBS letters 584 (1), 7-14, 2010 | 113 | 2010 |
| Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia Q Zhang, DMS Hossain, P Duttagupta, D Moreira, X Zhao, H Won, ... Blood, The Journal of the American Society of Hematology 127 (13), 1687-1700, 2016 | 100 | 2016 |
| TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy C Gao, A Kozlowska, S Nechaev, H Li, Q Zhang, DMS Hossain, ... Cancer research 73 (24), 7211-7221, 2013 | 96 | 2013 |
| Curcumin: the multi-targeted therapy for cancer regression DMS Hossain, S Bhattacharyya, T Das, G Sa Frontiers in Bioscience-Scholar 4 (1), 335-355, 2012 | 89 | 2012 |
| Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells L Lahiry, B Saha, J Chakraborty, A Adhikary, S Mohanty, DMS Hossain, ... Carcinogenesis 31 (2), 259-268, 2010 | 87 | 2010 |
| Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit S Saha, DMS Hossain, S Mukherjee, S Mohanty, M Mazumdar, ... BMC complementary and alternative medicine 13, 1-19, 2013 | 68 | 2013 |
| TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells D Moreira, Q Zhang, DMS Hossain, S Nechaev, H Li, CM Kowolik, ... Oncotarget 6 (19), 17302, 2015 | 66 | 2015 |
| MEK inhibition prevents tumour‐shed transforming growth factor‐β‐induced T‐regulatory cell augmentation in tumour milieu DMS Hossain, AK Panda, S Chakrabarty, P Bhattacharjee, K Kajal, ... Immunology 144 (4), 561-573, 2015 | 64 | 2015 |
| Gain of cellular adaptation due to prolonged p53 impairment leads to functional switchover from p53 to p73 during DNA damage in acute myeloid leukemia cells J Chakraborty, S Banerjee, P Ray, DMS Hossain, S Bhattacharyya, ... Journal of Biological Chemistry 285 (43), 33104-33112, 2010 | 47 | 2010 |
| Restoration of tumor suppressor p53 by differentially regulating pro-and anti-p53 networks in HPV-18-infected cervical cancer cells B Saha, A Adhikary, P Ray, S Saha, S Chakraborty, S Mohanty, K Das, ... Oncogene 31 (2), 173-186, 2012 | 41 | 2012 |
| Tumor-Shed PGE2 Impairs IL2Rγc-Signaling to Inhibit CD4+ T Cell Survival: Regulation by Theaflavins S Chattopadhyay, S Bhattacharyya, B Saha, J Chakraborty, S Mohanty, ... PLoS One 4 (10), e7382, 2009 | 40 | 2009 |
| Pazopanib as third line therapy for metastatic renal cell carcinoma: clinical efficacy and temporal analysis of cytokine profile SK Pal, DMS Hossain, Q Zhang, PH Frankel, JO Jones, C Carmichael, ... The Journal of urology 193 (4), 1114-1121, 2015 | 32 | 2015 |
Prof. Gaurisankar SaProfessor of Molecular Medicine, Bose Institute, Kolkata, IndiaVerified email at jcbose.ac.in